{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:16:24Z","timestamp":1761822984314},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,15]],"date-time":"2007-03-15T00:00:00Z","timestamp":1173916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,15]],"date-time":"2007-03-15T00:00:00Z","timestamp":1173916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s11060-007-9343-1","type":"journal-article","created":{"date-parts":[[2007,3,14]],"date-time":"2007-03-14T14:46:59Z","timestamp":1173883619000},"page":"71-77","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Temozolomide in glioblastoma: results of administration at first relapse and in newly diagnosed cases. Is still proposable an alternative schedule to concomitant protocol?"],"prefix":"10.1007","volume":"84","author":[{"given":"Manuela","family":"Caroli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Campanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annarita","family":"Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Prada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Borsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Martinelli-Boneschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Saladino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Maria","family":"Gaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,3,15]]},"reference":[{"key":"9343_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1023\/A:1008382516636","volume":"12","author":"M Brada","year":"2001","unstructured":"Brada M, Hoang-Xuan K, Rampling R, Dietrich P-Y, Dirix LY, Macdonald D, Heimans JJ, Zonnenberg BA, Bravo-Marques JM, Henriksson R, Stupp R, Yue N, Bruner J, Dugan M, Rao S, Zaknoen S (2001) Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 12:259\u2013266","journal-title":"Ann Oncol"},{"key":"9343_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1023\/A:1008336732273","volume":"12","author":"AA Brandes","year":"2001","unstructured":"Brandes AA, Ermani M, Basso U, Amist\u00e0 P, Berti F, Scienza R, Rotilio A, Pinna G, gardiman M, Monfardini S (2001) Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study. Ann Oncol 12:255\u2013257","journal-title":"Ann Oncol"},{"key":"9343_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/sj.bjc.6600135","volume":"86","author":"J Dinnes","year":"2002","unstructured":"Dinnes J, Cave C, Huang S, Milne R (2002) A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma. Br J Cancer 86:501\u2013505","journal-title":"Br J Cancer"},{"key":"9343_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/A:1015788814667","volume":"57","author":"S Trent","year":"2002","unstructured":"Trent S, Kong A, Short SC, Traish D, Ashley S, Dowe A, Hines F, Brada M (2002) Temozolomide as second-line chemotherapy for relapsed gliomas. J Neurooncol 57:247\u2013251","journal-title":"J Neurooncol"},{"key":"9343_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1054\/bjoc.2000.1316","volume":"83","author":"WK Yung","year":"2000","unstructured":"Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Wick NA, Rampling R, Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VAA (2000) phase II study of temozolomide versus procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83:588\u2013593","journal-title":"Br J Cancer"},{"key":"9343_CR6","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1200\/JCO.2005.00.331","volume":"23","author":"H Athanassiou","year":"2005","unstructured":"Athanassiou H, Synodinou M, Maradougakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P (2005) Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol 23:2372\u20132377","journal-title":"J Clin Oncol"},{"key":"9343_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00066-005-1359-x","volume":"181","author":"SE Combs","year":"2005","unstructured":"Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L, Wannenmacher M, Debus J (2005) Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Strahelenter Onkol 181:372\u2013377","journal-title":"Strahelenter Onkol"},{"key":"9343_CR8","first-page":"5159","volume":"23","author":"G Lanzetta","year":"2003","unstructured":"Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Secchione A (2003) Temozolomide in radio-chemotherapy combined treatment for newly diagnosed glioblastoma multiforme: phase II clinical trial. Anticancer Res 23:5159\u20135164","journal-title":"Anticancer Res"},{"key":"9343_CR9","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1200\/JCO.20.5.1375","volume":"20","author":"R Stupp","year":"2002","unstructured":"Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO, Leyvraz S (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20:1375\u20131382","journal-title":"J Clin Oncol"},{"key":"9343_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason Warren P, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Panzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"9343_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/B:NEON.0000021728.36747.93","volume":"67","author":"S Chibbaro","year":"2004","unstructured":"Chibbaro S, Benvenuti L, Caprio A, Carnesecchi S, Puler\u00e0 F, Faggionato F, Serino D, Galli C, Andreuccetti M, Buxton N, Gagliardi R (2004) Temozolomide as first-line agent in treating high-grade gliomas: phase II study. J Neuro-Oncol 67:77\u201381","journal-title":"J Neuro-Oncol"},{"key":"9343_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1215\/15228517-4-4-261","volume":"4","author":"MR Gilbert","year":"2002","unstructured":"Gilbert MR, Friedman HS, Kuttesch JF, Prados MD, Olson JJ, Reaman GH, Zaknoen SL (2002) A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neuro-Oncol 4:261\u2013267","journal-title":"Neuro-Oncol"},{"issue":"4","key":"9343_CR13","first-page":"355","volume":"3","author":"M Caroli","year":"2001","unstructured":"Caroli M, Locatelli M, Campanella R, Beretta F, Farina G, Scanni A, Arienta C (2001) Adjuvant chemotherapy after surgey of high grade gliomas: the role of tamoxifen and temozolomide. Neuro-Oncology 3(4):355, Abs no. 353","journal-title":"Neuro-Oncology"},{"key":"9343_CR14","unstructured":"Caroli M, Beretta F, Campanella R, Locatelli M, Prada F, Farina G, Scanni A, Arienta C (2002) Modified protocol with temozolomide in combination with tamoxifen as adjuvant chemotherapy after surgery of high grade gliomas. Neuro-Oncology 4(suppl 1):S18, Abs no. 71"},{"key":"9343_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(02)08091-1","volume":"359","author":"LA Stewart","year":"2002","unstructured":"Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011\u20131018","journal-title":"Lancet"},{"key":"9343_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10147-003-0339-3","volume":"8","author":"T Aoki","year":"2003","unstructured":"Aoki T, Mizutani T, Ishikawa M, Sugiyama K, Nobuo H (2003) A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme. Int J Clin Oncol 8:301\u2013304","journal-title":"Int J Clin Oncol"},{"key":"9343_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s004320050295","volume":"125","author":"F Paulsen","year":"1999","unstructured":"Paulsen F, Hoffmann W, Becker G, Belka C, Weinmann M, Classen J, Kortmann RD, Bamberg M (1999) Chemotherapy in the treatment od recurrent glioblastoma multiforme: ifosfamide versus temozolomide. J Cancer Res Clin Oncol 125:411\u2013418","journal-title":"J Cancer Res Clin Oncol"},{"key":"9343_CR18","first-page":"394","volume":"57","author":"L Sipos","year":"2004","unstructured":"Sipos L, Vitanovics D, Afra D (2004) Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas. Ideggyogy Sz 57:394\u2013399","journal-title":"Ideggyogy Sz"},{"key":"9343_CR19","first-page":"19","volume":"22","author":"MM Teixeira","year":"2002","unstructured":"Teixeira MM, Garcia I, Portela M, Cernuda M, Oliveira C, Albano J, Lima L (2002) Temozolomide in second-line treatment after prior nitrosurea-based chemotherapy in glioblastoma multiforme: experience from a Portuguese institution. Int J Clin Pharmacol Res 22:19\u201322","journal-title":"Int J Clin Pharmacol Res"},{"key":"9343_CR20","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1212\/01.WNL.0000127617.89363.84","volume":"62","author":"W Wick","year":"2004","unstructured":"Wick W, Steinbach JP, Kuker WM, Dichgans J, Bamberg M, Weller M (2004) One week on\/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. Neurology 62:2113\u20132115","journal-title":"Neurology"},{"key":"9343_CR21","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1002\/cncr.20224","volume":"101","author":"OL Chinot","year":"2004","unstructured":"Chinot OL, Barrie M, Frauger E, Dufour H, Branger D, Palmari J, Braguer D, Hoang-Xuan K, Moktari K, Peragut JC, Martin PM (2004) Grisoli F Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 101:2208\u20132214","journal-title":"Cancer"},{"key":"9343_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/cncr.11097","volume":"97","author":"AA Brandes","year":"2003","unstructured":"Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A, Gardiman M, Scienza R, Monfardini S, Ermani M (2003) A prospective study on glioblastoma in the elderly. Cancer 97:657\u2013662","journal-title":"Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-007-9343-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-007-9343-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-007-9343-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-007-9343-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T06:33:41Z","timestamp":1652596421000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-007-9343-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,15]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["9343"],"URL":"https:\/\/doi.org\/10.1007\/s11060-007-9343-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,15]]},"assertion":[{"value":"4 December 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}